Impact of New Cardiovascular Events on Quality of Life and Hospital Costs in People With Cardiovascular Disease in the United Kingdom and United States.
Journal article
Lui JNM. et al, (2023), J Am Heart Assoc, 12
ASCEND-Eye: Rationale, design and baseline characteristics for a sub-study of the ASCEND randomized trial, exploring the effects of aspirin and omega-3 fatty acids on diabetic retinopathy and age-related macular degeneration
Journal article
SAMMONS E. et al, (2023), Contemporary Clinical Trials Communications
Reliability of major bleeding events in UK routine data versus clinical trial adjudicated follow-up data.
Journal article
Harper C. et al, (2023), Heart
Randomized Trials Fit for the 21st Century: A Joint Opinion From the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation
Journal article
Bowman L. et al, (2023), Journal of the American College of Cardiology, 81, 1205 - 1210
Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial.
Journal article
Parish S. et al, (2023), Trials, 24
Randomized trials fit for the 21st century. A joint opinion from the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation.
Journal article
Bowman L. et al, (2022), Eur Heart J
Randomized Trials Fit for the 21st Century: A Joint Opinion From the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation.
Journal article
Bowman L. et al, (2022), Circulation
Randomized Trials Fit for the 21st Century: A Joint Opinion From the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation
Journal article
Bowman L. et al, (2022), Circulation
Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials.
Journal article
Cholesterol Treatment Trialists' Collaboration None., (2022), Lancet, 400, 832 - 845
Hospital costs associated with adverse events in people with diabetes in the UK.
Journal article
Keng MJ. et al, (2022), Diabetes Obes Metab
Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial.
Journal article
Parish S. et al, (2022), Eur Heart J, 43, 2010 - 2019
Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.
Journal article
HPS3/TIMI55-REVEAL Collaborative Group None. et al, (2022), Eur Heart J, 43, 1416 - 1424
Decrements in health-related quality of life associated with adverse events in people with diabetes.
Journal article
Keng MJ. et al, (2022), Diabetes Obes Metab, 24, 530 - 538
Randomized Trials Fit for the 21st Century. A Joint Opinion from the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation.
Journal article
Bowman L. et al, (2022), Glob Heart, 17
Comparison of the Accuracy and Completeness of Records of Serious Vascular Events in Routinely Collected Data vs Clinical Trial-Adjudicated Direct Follow-up Data in the UK: Secondary Analysis of the ASCEND Randomized Clinical Trial.
Journal article
Harper C. et al, (2021), JAMA Netw Open, 4
Comparison of the Accuracy and Completeness of Records of Serious Vascular Events in Routinely Collected Data vs Clinical Trial-Adjudicated Direct Follow-up Data in the UK: Secondary Analysis of the ASCEND Randomized Clinical Trial.
Journal article
Harper C. et al, (2021), JAMA Netw Open, 4
Performance of the UKPDS Outcomes Model 2 in a contemporary UK type 2 diabetes trial cohort
Journal article
Keng MJ. et al, (2021), Value in Health
Realising the full potential of data-enabled trials in the UK: a call for action
Journal article
LANDRAY M. et al, (2021), BMJ Open
Realising the full potential of data-enabled trials in the UK: a call for action
Journal article
LANDRAY M. et al, (2021), BMJ Open
Performance of the UK Prospective Diabetes Study Outcomes Model 2 in a Contemporary UK Type 2 Diabetes Trial Cohort
Journal article
Keng M. et al, (2021), Value in Health